HER2-POSITIVE ADVANCED BREAST CANCER
Clinical trials for HER2-POSITIVE ADVANCED BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2-POSITIVE ADVANCED BREAST CANCER trials appear
Sign up with your email to follow new studies for HER2-POSITIVE ADVANCED BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World study checks T-DM1 safety and effectiveness in chinese breast cancer patients
Disease control CompletedThis study looked at 178 Chinese patients with HER2-positive advanced breast cancer who received the drug T-DM1 after earlier treatments failed. Researchers tracked side effects and how long the drug kept the cancer from getting worse. The goal was to see how well T-DM1 works in …
Matched conditions: HER2-POSITIVE ADVANCED BREAST CANCER
Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug FS1502 targets Hard-to-Treat HER2 cancers in early trial
Disease control CompletedThis early-phase trial tested an experimental drug called FS1502 in 161 people with advanced solid tumors or breast cancer that express HER2. The study had two parts: first, finding a safe dose, and then seeing how well that dose works. The goal was to check safety and early sign…
Matched conditions: HER2-POSITIVE ADVANCED BREAST CANCER
Phase: PHASE1 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:21 UTC